Pharmatech Associates Adds Biotech Leader Praveen Tyle, Ph.D. to Board of Trustees

2024-01-16

高管变更

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, a subsidiary of the United States Pharmacopeia (USP), today announced it has appointed the biotech expert Dr. Praveen Tyle to its board of trustees. In nearly 40 years’ experience with small and large biotech organizations, Dr. Tyle has served as executive vice president and chief science officer at USP, and held leadership positions at Lexicon Pharmaceuticals, Osmotica Pharmaceutical, Novartis Consumer Health Group, and Bausch + Lomb.

'As we focus on providing expert consulting services to an array of biotechnology clients, Dr. Tyle\u2019s incomparable experience and valuable market insight will inform the Pharmatech Associates board'

“As we focus on providing expert consulting services to an array of biotechnology clients, Dr. Tyle’s incomparable experience and valuable market insight will inform the Pharmatech Associates board,” said Emily Kaine, Pharmatech Associates’ board chair. “Dr. Tyle’s commitment and deep understanding of USP also ensure that Pharmatech Associates’ strategic direction contributes to USP’s long term vision of advancing global access to quality medicines.”

“Pharmatech Associates’ capability building services and technical solutions for life sciences companies are a perfect complement to USP’s portfolio of standards and related programs,” said Dr. Tyle. “Backed by USP’s sustained investment and global network, Pharmatech has a promising, ambitious long-term global growth trajectory as it helps drug manufacturers meet international regulatory requirements and their own business objectives.”

About Pharmatech Associates – a USP Company

Pharmatech Associates is a global consultancy for the life science industry and advises U.S. and global drug sponsors and manufacturers that supply quality medicines in many major markets. As a wholly owned subsidiary of U.S. Pharmacopeia (USP) with domain expertise ranging from small molecule to cell and gene therapy, biologics—specifically monoclonal antibodies— and advanced manufacturing technologies, Pharmatech Associates’ services include product and process development, quality management, quality assurance, and product management. Pharmatech Associates assists clients in navigating the regulatory landscape of the FDA and international health authorities and provides guidance for U.S. market entry. Pharmatech Associates serves a range of clients from start-ups to large multi-national corporations from its headquarters in the San Francisco Bay area.

Learn more at www.pharmatechassociates.com.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构